Ocutec Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 6

Ocutec General Information

Description

Developer of soft contact lenses designed to offer the freedom to see without wearing spectacles. The company's lenses utilize polyethylene glycol (PEG) polymer chemistry that deploys step-growth polymerization to achieve optimum reaction, enabling patients and users to get hydrated lens surfaces that behave like the extracellular matrix, supporting tear film stability, ocular health, and wearing comfort.

Contact Information

Website
www.ocutec.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3 Clark Way, Bellshill Industrial Estate
  • Bellshill ML4 3NX
  • Scotland, United Kingdom
+44 01698
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
LOHAS & Wellness
Corporate Office
  • 3 Clark Way, Bellshill Industrial Estate
  • Bellshill ML4 3NX
  • Scotland, United Kingdom
+44 01698

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ocutec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private Completed Generating Revenue
11. Later Stage VC 23-Dec-2021 Completed Generating Revenue
10. Later Stage VC 24-Oct-2018 Completed Product Development
9. Later Stage VC 26-Mar-2018 Completed Product Development
8. Later Stage VC 04-Oct-2016 Completed Product Development
7. Later Stage VC 08-Jun-2015 Completed Product Development
6. Later Stage VC 17-Jun-2014 Completed Product Development
5. Later Stage VC 03-Jun-2010 Completed Product Development
4. Later Stage VC 15-Apr-2009 $838K $2.74M Completed Product Development
3. Later Stage VC 01-Aug-2008 $1.42M $1.91M Completed Product Development
To view Ocutec’s complete valuation and funding history, request access »

Ocutec Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
Seed
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 11,078 $0.013273 $50.44 $50.44 1x $50.44 0.46%
Ordinary 3,147 $0.013273 $210.83 $210.83 1x $210.83 0.13%
To view Ocutec’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ocutec Patents

  • 120

    Total Documents Applications and Grants

  • Total Patents Families

  • 41

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Ocutec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202002456-D0 Optimised contact lens package Inactive 21-Feb-2020
GB-202001721-D0 Optimised contact lens package Inactive 07-Feb-2020
JP-7454552-B2 Compound Active 14-Aug-2018
EP-3836980-A1 Formulation Active 14-Aug-2018
EP-3836980-B1 Formulation Active 14-Aug-2018 A61L27/34
To view Ocutec’s complete patent history, request access »

Ocutec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ocutec Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Intuitive Investments Group Asset Manager Minority
KCP Nominees Corporation Minority
ChimaeraBio Corporation Minority
Discovery Investment Fund Venture Capital Minority
Scottish Enterprise Government Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Ocutec FAQs

  • When was Ocutec founded?

    Ocutec was founded in 2001.

  • Where is Ocutec headquartered?

    Ocutec is headquartered in Bellshill, United Kingdom.

  • What is the size of Ocutec?

    Ocutec has 14 total employees.

  • What industry is Ocutec in?

    Ocutec’s primary industry is Therapeutic Devices.

  • Is Ocutec a private or public company?

    Ocutec is a Private company.

  • What is Ocutec’s current revenue?

    The current revenue for Ocutec is .

  • How much funding has Ocutec raised over time?

    Ocutec has raised $10.9M.

  • Who are Ocutec’s investors?

    Intuitive Investments Group, KCP Nominees, ChimaeraBio, Discovery Investment Fund, and Scottish Enterprise are 5 of 6 investors who have invested in Ocutec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »